Clinical trial Recruiting at 1 site Observational Ages 10 to 17

Turkish version of the Scoliosis Misconception Scale for adolescents with AIS

Official title: Cross-Cultural Adaptation and Psychometric Validation of the Turkish Scoliosis Misconception Scale in Patients With Adolescent Idiopathic Scoliosis

Run by Kahramanmaras Sutcu Imam University · NCT07909174 · Data updated 2026-11-12

This study tests a Turkish version of the Scoliosis Misconception Scale in 200 adolescents with AIS to see if the questions reliably measure misconceptions about scoliosis.

More Adolescent Idiopathic Scoliosis (AIS) trials

Quick facts

Study typeObservational
Ages10 Years to 17 Years
SexAll
Enrollment200 (estimated)
SponsorKahramanmaras Sutcu Imam University
Academic / other
Locations1 site (Kahramanmaraş, Kahramanmaraş)
StatusRecruiting
StartedOctober 21, 2026
Main results expectedNovember 2026
Study endsNovember 2026
Registry record updatedNovember 2, 2026
Trial IDNCT07909174 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adolescents aged 10-17 with AIS and Cobb angle ≥10° who can understand and respond to Turkish questionnaire items.

Probably not a fit

Patients who do not speak Turkish well or have conditions preventing reliable questionnaire completion may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational, cross-cultural adaptation study that translates and validates the Scoliosis Misconception Scale (SMS) for Turkish-speaking adolescents with AIS. The project will recruit 200 participants aged 10-17 with Cobb angle ≥10°, administer the 17-item SMS, and re-administer to a subset after about two weeks to assess test-retest reliability. Psychometric analyses will include internal consistency, item properties, and reliability; item response theory may be used if data allow. The goal is to establish the Turkish SMS as a reliable and valid tool for assessing misconceptions about AIS in this population. The study follows a forward-backward translation process with expert review and pilot testing to ensure cultural appropriateness.

Why it matters

Potential benefit: If successful, clinicians and researchers will have a validated Turkish tool to assess patients' misconceptions about AIS, informing education and communication strategies.

How similar studies have gone: Previous cross-cultural adaptations of the SMS in other languages have demonstrated acceptable reliability and validity, supporting this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adolescents aged 10-17 years.
* Confirmed diagnosis of adolescent idiopathic scoliosis (AIS).
* Radiographically confirmed spinal curvature with a Cobb angle of at least 10°.
* Ability to understand and respond to the Turkish version of the questionnaire.
* Written informed consent from a parent or legal guardian and age-appropriate assent from the adolescent.

Exclusion Criteria:

* Non-idiopathic scoliosis, including congenital, neuromuscular, or syndromic scoliosis.
* Previous spinal surgery for scoliosis.
* Cognitive or communication impairments that prevent reliable questionnaire completion.
* Inability to complete the questionnaire independently or with the standardized assistance permitted by the study protocol.

Where it's running

  • Mehmet Emin Sigindim Private Physiotherapy Practice
    Kahramanmaraş, Kahramanmaraş, Turkey (Türkiye)
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.